The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLEK.L Regulatory News (LEK)

  • There is currently no data for LEK

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Corporate Update

16 May 2022 07:00

RNS Number : 5278L
Lekoil Limited
16 May 2022
 

16 May 2022

Lekoil Limited

("LEKOIL" or the "Company")

Notice of application for admission to the Aquis Stock Exchange and Cancellation of Admission to trading on AIM

LEKOIL (AIM: LEK), announces that it has applied for admission of its Ordinary Shares to trading on the Access segment of the AQSE Growth Market operated by the Aquis Stock Exchange (AQSE). It is expected that admission will occur on 18 May 2022 and that trading will commence on AQSE as soon as the audited accounts for the Company are released to the market, expected to be by the end of June 2022.

 

The Company's Ordinary Shares have been suspended from trading on AIM since October 2021. Pursuant to AIM Rule 41, admission of the Company's shares to trading on AIM will be cancelled with effect from 7.00 a.m. on 18 May 2022 with the Company's shares being admitted to trading on the AQSE Growth Market from this time.

Moving from AIM to AQSE will not affect a shareholder's legal or beneficial right to his or her shares. Shareholders are not required to take any action at this stage.

 

Anthony Hawkins, Interim Executive Chairman, commented:

"The Board of the Company considers AQSE to be a suitable exchange to provide for the continued listing of its shares.

The Board is of the view that the Company's primary activity is now the recovery of its investment through litigation against the Lekoil Nigeria group and Mr. Akinyanmi. This characterisation will allow the Company to fulfil its disclosure obligations to the AQSE market, noting that a successful recovery of the intercompany debts due to the Company will be the primary source of value for shareholders (with minimal value attributable to the day-to-day operational activities of Lekoil Nigeria).

With respect to the suspension of the Company's shares from trading on AQSE, the Company has a clear understanding as to what is required to restore trading in the Company's shares on AQSE and we are diligently working through that plan. We will update our shareholders on this matter as soon as is practicable.

In selecting the AQSE Growth Market, the Board was keen to provide shareholders with the services of a regulated SME Growth market and a trading facility while it pursues its litigation assets, and its strategy unfolds."

 

With effect from the cancellation of the admission of the Company's shares to trading on AIM SP Angel Corporate Finance LLP will cease to act as Nominated Adviser and joint broker to the Company.

 

The Company's shares will continue to be registered with the existing ISIN number KYG5462G1073 and SEDOL number B9FFQF9. The Company's ticker symbol will continue to be LEK.

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ('MAR'). Upon the publication of this announcement via Regulatory Information Service ('RIS'), this inside information is now considered to be in the public domain.

 

For further information, please visit www.lekoilplc.com or contact:

Lekoil Limited

Anthony Hawkins

 

info@lekoilplc.com

SP Angel Corporate Finance LLP (AIM Nominated Adviser and Joint Broker)

Jeff Keating / Stuart Gledhill

 

+44 20 3470 0470

First Sentinel Corporate Finance Limited (AQSE Corporate Adviser)

Brian Stockbridge

 

+44 20 3989 2200

Tennyson Securities (Joint Broker)

Peter Krens / Edward Haig-Thomas

+44 20 7186 9030

Camarco (Financial PR Advisor)

Billy Clegg / Owen Roberts / Violet Wilson

+44 20 3757 4983

  

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDAAMLTMTIBMAT
Date   Source Headline
20th Apr 20204:36 pmRNSPrice Monitoring Extension
16th Apr 20204:41 pmRNSSecond Price Monitoring Extn
16th Apr 20204:36 pmRNSPrice Monitoring Extension
16th Apr 202012:07 pmRNSSecond Price Monitoring Extn
16th Apr 202012:03 pmRNSPrice Monitoring Extension
15th Apr 20204:40 pmRNSSecond Price Monitoring Extn
15th Apr 20204:36 pmRNSPrice Monitoring Extension
15th Apr 202012:08 pmRNSSecond Price Monitoring Extn
15th Apr 202012:03 pmRNSPrice Monitoring Extension
3rd Apr 20207:00 amRNSCost Reduction Measures and Optimum Payment
2nd Apr 20204:41 pmRNSSecond Price Monitoring Extn
2nd Apr 20204:36 pmRNSPrice Monitoring Extension
31st Mar 202011:35 amRNSTR-1: Notification of Major Holdings
25th Mar 20207:00 amRNSProcessing of Payment for OPL 310 Ongoing
11th Mar 202012:07 pmRNSSecond Price Monitoring Extn
11th Mar 202012:02 pmRNSPrice Monitoring Extension
10th Mar 202012:07 pmRNSSecond Price Monitoring Extn
10th Mar 202012:02 pmRNSPrice Monitoring Extension
2nd Mar 20207:00 amRNSInvestigation into OPL 310 Facility Agreement
27th Feb 20204:40 pmRNSSecond Price Monitoring Extn
27th Feb 20204:35 pmRNSPrice Monitoring Extension
26th Feb 20204:17 pmRNSTR-1: Notification of major holdings
27th Jan 20207:00 amRNSUpdate on Otakikpo Operations
21st Jan 20204:40 pmRNSSecond Price Monitoring Extn
21st Jan 20204:35 pmRNSPrice Monitoring Extension
21st Jan 20202:29 pmRNSOPL 310 Project Update
15th Jan 20205:20 pmRNSTR-1: Notification of major holdings
14th Jan 20207:30 amRNSRestoration - Lekoil Limited
13th Jan 20206:04 pmRNSFurther update on Facility Agreement and Trading
13th Jan 20207:50 amRNSSuspension - Lekoil Limited
13th Jan 20207:46 amRNSSuspension of Trading on AIM
10th Jan 20207:00 amRNSCommencement of Site Survey on OPL 310
7th Jan 20209:11 amRNSHolding(s) in Company
6th Jan 20207:00 amRNSDirectorate Changes
3rd Jan 202011:18 amRNSHolding(s) in Company
2nd Jan 202012:07 pmRNSSecond Price Monitoring Extn
2nd Jan 202012:02 pmRNSPrice Monitoring Extension
2nd Jan 20207:00 amRNSOPL 310 Appraisal Funding Secured
20th Dec 20197:00 amRNSRepayment of Outstanding Advance Payment Facility
13th Dec 20194:40 pmRNSSecond Price Monitoring Extn
13th Dec 20194:35 pmRNSPrice Monitoring Extension
15th Nov 20197:00 amRNSAcknowledgment of OPL310 Licence Extension Payment
14th Nov 20194:40 pmRNSSecond Price Monitoring Extn
14th Nov 20194:35 pmRNSPrice Monitoring Extension
31st Oct 20197:00 amRNSOPL 310 Licence Extension Terms Fulfilled
25th Oct 20194:31 pmRNSNew Debt Facility with FBNQuest Merchant Bank
21st Oct 20197:00 amRNSOtakikpo Update
27th Sep 20197:00 amRNSHalf Year Results for the 6 Months to 30 June 2019
6th Sep 20197:00 amRNSExtension of OPL 310 Licence
30th Aug 20197:00 amRNSJoint update with OPL 310 Operator

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.